发明名称 |
TRANSDERMAL BUPRENORPHINE TO TREAT PAIN IN SICKLE CELL CRISIS |
摘要 |
<p>A specific dosage regimen of buprenorphine achieves pain relief from painful episodes due to sickle cell disease. The dosage regimen comprises administering to a patient in need of pain relief from sickle cell disease at least one BTDS transdermal patch. Alternatively, the dosing regimen comprises administering to the patient (1) a first buprenorphine-containing transdermal dosage form for a first dosing period; (2) administering to the patient a second buprenorphine-containing transdermal dosage form for a second dosing period, where the second dosage form comprises the same dosage of buprenorphine as, or a greater dosage of buprenorphine than, the first dosage form; and (3) administering to the patient a third buprenorphinecontaining transdermal dosage form for a third dosing period, where the third dosage form comprises a greater dosage of buprenorphine than the second dosage form.</p> |
申请公布号 |
WO2004054554(A1) |
申请公布日期 |
2004.07.01 |
申请号 |
WO2003US39793 |
申请日期 |
2003.12.15 |
申请人 |
EURO-CELTIQUE S.A.;REIDENBERG, BRUCE, E.;SPYKER, DANIEL, A. |
发明人 |
REIDENBERG, BRUCE, E.;SPYKER, DANIEL, A. |
分类号 |
A61K9/70;A61K31/485;A61K45/06;(IPC1-7):A61K9/70 |
主分类号 |
A61K9/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|